Evidence map›Paper›PMID 38935213›Full record

ArticleHealth & justice2024

Rapid jail-based implementation of overdose education and naloxone distribution in response to the COVID-19 pandemic.

Carrie B Oser, Margaret McGladrey, Marisa Booty, Hilary Surratt, Hannah K Knudsen, Patricia R Freeman, Danelle Stevens-Watkins, Monica F Roberts, Michele Staton, April Young and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Health & justice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04111939 (HEALing Communities Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04111939 nacompletednot on this map

HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Opioid Crisis

TypeinterventionalSponsorRTI InternationalRan2019 to 2025Enrolled67ConditionsOpioid Use Disorder (OUD)ArmsCommunities That HEAL, Wait-list control
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carrie B OserDepartment of Sociology, Center for Health Equity Transformation, Center on Drug & Alcohol Research, University of Kentucky, 1531 Patterson Office Tower, Lexington, KY, 40506, USA. carrie.oser@uky.edu.ORCID http://orcid.org/0000-0001-8658-9335
Margaret McGladreyDepartment of Health Management and Policy, Center for Innovation in Population Health, University of Kentucky, 111 Washington Avenue, Lexington, KY, 40508, USA.
Marisa BootyDepartment of Sociology, University of Kentucky, 1515 Patterson Office Tower, Lexington, KY, 40506, USA.
Hilary SurrattDepartment of Behavioral Science, Center on Drug & Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA.
Hannah K KnudsenDepartment of Behavioral Science, Center on Drug & Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA.
Patricia R FreemanDepartment of Pharmacy Practice & Science, Center for the Advance of Pharmacy Practice, University of Kentucky, 789 S. Limestone, Lexington, KY 40508, USA.
Danelle Stevens-WatkinsDepartment of Educational, School, and Counseling Psychology, Center on Drug & Alcohol Research, University of Kentucky, 103 Dickey Hall, Lexington, KY 40506, USA.
Monica F RobertsSubstance Use Priority Research Area, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA.
Michele StatonDepartment of Behavioral Science, Center on Drug & Alcohol Research, University of Kentucky, 1100 Veterans Drive, Medical Behavioral Science Building, Lexington, KY, 40536, USA.
April YoungDepartment of Epidemiology and Environmental Health, Center on Drug & Alcohol Research, University of Kentucky, 111 Washington Ave, Lexington, KY 40508, USA.
Emma DraperDepartment of Psychology, Williams College, 25 Stetson Ct., Williamstown, MA, 01267, USA.
Sharon L WalshDepartment of Behavioral Science, Center on Drug & Alcohol Research, University of Kentucky, 845 Angliana Avenue, Lexington, KY 40508, USA.

Funding

Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term)UM1DA049406 · NIDA · UNIVERSITY OF KENTUCKY · PI WALSH, SHARON L. · 2019 to 2022
$81.7M
NIDA NIH HHS UM1 DA049406NIDA NIH HHS UM1DA049406
6 · The paper itself

Abstract

backgroundPeople incarcerated in jails are highly impacted by the opioid epidemic, and overdose education and naloxone distribution (OEND) is an effective strategy to reduce opioid overdose deaths. This study examines barriers and facilitators of fast-track OEND implementation within the jails in the Wave 1 Kentucky counties of the HEALing Communities Study during the COVID-19 pandemic.

methodsMeeting minutes with jail stakeholders were qualitatively coded using the Practical, Robust Implementation and Sustainability Model (PRISM) as the coding framework. The analysis highlighted the top barriers and facilitators to fast-track OEND implementation within the PRISM framework.

resultsSpace and staffing shortages related to the COVID-19 pandemic, disruptions in interorganizational programming from pandemic-related service suspensions, and a lack of technological solutions (e.g., reliable Internet access) for socially distanced delivery were the top barriers to fast-track OEND implementation. In addition, there were limitations on non-jail staff access to jails during COVID-19. Top facilitators included jail leadership support, the option to prioritize high-risk groups, and the incorporation of OEND processes into existing communications and management software. While the COVID-19 pandemic strained jail infrastructure, jail and partner agency collaboration led to creative implementation strategies for the successful integration of OEND into jail operations. Urban jails were more likely than rural jails to be early adopters of OEND during the public health emergency.

conclusionsUnderstanding the barriers to and facilitators of OEND within jails will improve implementation efforts seeking to curb opioid overdose deaths. Jail leadership support and interorganizational efforts were key facilitators to implementation; therefore, it is recommended to increase buy-in with multiple agencies to promote success. Challenges brought on by COVID-19 have resulted in a need for innovative solutions for implementation. CLINICAL TRIAL INFORMATION: ClinicalTrials.gov, NCT04111939, Submitted 30 September 2019, https://clinicaltrials.gov/study/NCT04111939?titles=HEALing%20Communities%20Study&rank=1 .

Indexed as

COVID-19 pandemicImplementation scienceJailsNaloxonePractical, robust implementation and sustainability model (PRISM)

Identifiers

PMID38935213
PMCPMC11212218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.